(Q42550353)

2 November 2017

title

Medium chain acyl-CoA dehydrogenase deficiency and fatal valproate toxicity (English)

1 reference

medium chain acyl-CoA dehydrogenase deficiency

2 November 2017

main subject

0 references

1

Njølstad PR

1 reference

2 November 2017

6

Søvik O

1 reference

2 November 2017

Skjeldal OH

2

1 reference

2 November 2017

Agsteribbe E

3

1 reference

2 November 2017

Huckriede A

4

1 reference

2 November 2017

Wannag E

5

1 reference

2 November 2017

Waaler PE

7

1 reference

2 November 2017

publication date

1 February 1997

1 reference

2 November 2017

1 reference

2 November 2017

volume

16

1 reference

2 November 2017

issue

2

1 reference

2 November 2017

page(s)

160-162

1 reference

Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children.

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2896%2900318-9

7 January 2021

Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2896%2900318-9

7 January 2021

Medium chain acyl-CoA dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2896%2900318-9

7 January 2021

Valproic acid hepatic fatalities. II. US experience since 1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2896%2900318-9

7 January 2021

Associations Between Risk Factors for Valproate Hepatotoxicity and Altered Valproate Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2896%2900318-9

7 January 2021

Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2896%2900318-9

7 January 2021

Medium-chain acyl-CoA dehydrogenase deficiency: molecular aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2896%2900318-9

7 January 2021

Valproate-associated hepatotoxicity and its biochemical mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2896%2900318-9

7 January 2021

Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2896%2900318-9

7 January 2021

Fatal liver failure in 16 children with valproate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2896%2900318-9

7 January 2021

10.1016/S0887-8994(96)00318-9

Identifiers

DOI

1 reference

2 November 2017

1 reference